Eli Lil­ly's tirzepatide is the king of the GLP-1s, but oth­er op­tions are com­ing

Eli Lil­ly’s tirzepatide is still the most ef­fec­tive weight-loss treat­ment to date, ac­cord­ing to de­tailed da­ta from its Phase III SUR­MOUNT-2 study re­leased at the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.